Home > News & resources > News > Scope 63 - Research From Bench to Bedside

Scope 63 - Research From Bench to Bedside

7 August 2017

Every scientific researcher’s ultimate aim is to discover and develop new treatments to cure diseases and improve human health.

The Malaghan Institute is a very unique place to translate bench side research into real treatments.

“We decided early that we wanted to move novel ideas into the clinic as soon as possible,” explains Professor Ian Hermans, Leader of our Cancer Immunotherapy Programme. “Thanks to governmental funding and the noteworthy support of our donors, the Institute is in a distinctive position to invest in specialized laboratories and staff.” With the cutting edge research technology and the treatment-based approach that the Institute provides, Prof Hermans’ research has advanced a cell-based cancer vaccine into clinical trials.